This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
THE OLD DIPSOMANIAC by Billy Roberts
January 29, 2019
NOVEMBER THOUGHTS by Billy Roberts
January 29, 2019
After the diagnosis by Christian Wiman
January 29, 2019
In Appreciation of the Carer
January 29, 2019
#WorldAspergillosisDay 2019
January 25, 2019
Amphotericin B-resistance found in some Aspergillus isolates.
January 25, 2019
Poetry at the GAFFI Launch
January 23, 2019
Decomposition: An Anthology of Fungi-Inspired Poems
January 23, 2019
11 irregular stanzas on trimming toenails by Kat Couch
January 23, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video